Insufficient scRNA-seq data for expression of CYP27C1 at single-cell level.
Insufficient scRNA-seq data for expression of CYP27C1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 93% | 225.52 | 158 / 170 | 63% | 5.03 | 291 / 459 |
bladder | 95% | 282.29 | 20 / 21 | 43% | 2.82 | 219 / 504 |
esophagus | 73% | 138.44 | 1052 / 1445 | 49% | 4.02 | 90 / 183 |
skin | 78% | 481.26 | 1420 / 1809 | 40% | 2.27 | 188 / 472 |
intestine | 93% | 203.57 | 896 / 966 | 8% | 0.23 | 44 / 527 |
prostate | 99% | 223.44 | 242 / 245 | 1% | 0.03 | 7 / 502 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.94 | 1 / 1 |
adipose | 89% | 140.74 | 1069 / 1204 | 0% | 0 | 0 / 0 |
breast | 68% | 72.58 | 314 / 459 | 16% | 0.79 | 175 / 1118 |
brain | 19% | 27.24 | 501 / 2642 | 64% | 2.34 | 449 / 705 |
tonsil | 0% | 0 | 0 / 0 | 76% | 5.82 | 34 / 45 |
pancreas | 3% | 1.59 | 10 / 328 | 63% | 2.49 | 112 / 178 |
kidney | 46% | 38.07 | 41 / 89 | 13% | 0.54 | 116 / 901 |
lung | 14% | 10.19 | 80 / 578 | 44% | 2.18 | 506 / 1155 |
heart | 54% | 83.49 | 465 / 861 | 0% | 0 | 0 / 0 |
stomach | 43% | 55.89 | 156 / 359 | 8% | 0.16 | 22 / 286 |
ovary | 39% | 43.19 | 71 / 180 | 5% | 0.09 | 23 / 430 |
adrenal gland | 31% | 30.22 | 79 / 258 | 13% | 0.34 | 29 / 230 |
thymus | 27% | 17.80 | 179 / 653 | 8% | 0.29 | 49 / 605 |
liver | 19% | 12.64 | 42 / 226 | 11% | 0.25 | 46 / 406 |
spleen | 29% | 18.61 | 70 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 29% | 26.50 | 387 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 21% | 0.46 | 17 / 80 |
muscle | 7% | 4.24 | 53 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
peripheral blood | 0% | 0.10 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042574 | Biological process | retinal metabolic process |
GO_0042573 | Biological process | retinoic acid metabolic process |
GO_0042572 | Biological process | retinol metabolic process |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0061897 | Molecular function | all-trans retinal 3,4-desaturase activity |
GO_1904768 | Molecular function | all-trans-retinol binding |
GO_0061898 | Molecular function | all-trans retinoic acid 3,4-desaturase activity |
GO_0004497 | Molecular function | monooxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0005503 | Molecular function | all-trans retinal binding |
GO_0061896 | Molecular function | all-trans retinol 3,4-desaturase activity |
GO_0005502 | Molecular function | 11-cis retinal binding |
GO_0020037 | Molecular function | heme binding |
GO_0001972 | Molecular function | retinoic acid binding |
GO_0061899 | Molecular function | 11-cis-retinal 3,4-desaturase activity |
Gene name | CYP27C1 |
Protein name | Cytochrome P450 family 27 subfamily C member 1 Cytochrome P450 27C1 (EC 1.14.19.53) (All-trans retinol 3,4-desaturase) |
Synonyms | |
Description | FUNCTION: [Isoform 2]: A cytochrome P450 monooxygenase that catalyzes the 3,4 desaturation of all-trans-retinol (also called vitamin A1) to all-trans-3,4-didehydroretinol (also called vitamin A2) in the skin. Desaturates with lower efficiency all-trans retinal and all-trans retinoic acid. Forms minor amounts of 3-hydroxy and 4-hydroxy all-trans-retinol derivatives. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate and reducing the second into a water molecule. Two electrons are provided by NADPH via a two-protein mitochondrial transfer system comprising flavoprotein FDXR (adrenodoxin/ferredoxin reductase) and nonheme iron-sulfur protein FDX1 or FDX2 (adrenodoxin/ferredoxin). . |
Accessions | ENST00000335247.11 [Q4G0S4-1] A0A7N4I3A3 ENST00000409327.2 [Q4G0S4-1] ENST00000664447.2 Q4G0S4 |